Silvio Garattini - Istituto di Ricerche Farmacologiche Mario Negri

Silvio Garattini Prof. Silvio Garattini was born in Bergamo (Italy) on 12 November 1928. He earned a diploma in chemistry, then a degree in medicine, and was appointed lecturer in chemotherapy and pharmacology. He held the post of Assistant then Deputy Professor at the Milan University Institute of Pharmacology until 1962. In 1961 he founded the Mario Negri Institute for Pharmacological Research, and was nominated by Mario Negri as its director, the post he has held since it opened in 1963. The Institute now has THREE locations ‐‐ Milan, Bergamo and Ranica (Bg) ‐‐ and more than 950 people work there. Professor Garattini is a member of the Gruppo 2003 (a group of the most cited Italian scientists in international scientific literature) and has published hundreds of articles in Italian and English in international scientific journals, and texts on pharmacology. He was a founder of the European Organisation for Research and Treatment of Cancer (EORTC). Over the last decades Professor Garattini has acted in various organizations, including the Italian National Research Council (CNR) ‐ Committee on Biology and Medicine; the National Health Council, the Committee for Italian Research Policy, set up by the Presidency of the Council of Ministers; the Ministry of Health Commissione Unica del Farmaco (CUF). He has held the following posts: President of the UICC Committee on Antitumoral Chemotherapy, President of the European Organisation for Research and Treatment of Cancer (EORTC), consultant to the World Health Organisation (WHO), member of the Board of the Italian Istituto Superiore di Sanità(ISS), President of the European Society of Biochemical Pharmacology, member of the Committee for Proprietary Medicinal Products (CPMP) of the European Agency for the Evaluation of Medicinal Products (EMA), the Committee of Experts for Research Policy (CEPR) at the Italian Ministry for University and Scientific and Technological Research, and the Scientific Committee of the Lega Italiana per la Lotta Contro i Tumori (LILT); President of the 5th section of the Consiglio Superiore di Sanità (CSS), Chairman of the Commission for Research and Development of the Agenzia Italiana del Farmaco (AIFA), President of the Technical Commission for Pharmaceutical Assistance of the Sardinian Regione Autonoma; member of the Lombardy Region Strategic Committee for Welfare, of the AISLA Scientific Committee, the International Scientific Committee of the Centro di Riferimento Oncologico Aviano, the Scientific Committee of the Council of Ministers Presidency Antidrug Policy Department, the Advisory Board, ADAMO Onlus, Milan, and the Committee of the “Recommendation for the Call”, Wemos Foundation, Amsterdam. He currently holds other important posts, such as President of the Angelo and Angela Valenti Foundation, of the "Via di Natale" Foundation, permanent member of the CSS, member of the National Bioethics Committee, and of the Sicilian Regional Bioethics Committee. Professor Garattini has received numerous awards for his work, including the French Legion d'Honneur for scientific merit, and the Medaglia d’Oro al Merito della Sanità Pubblica of the Italian Ministry of Health, the Medal of the Società Italiana di Chimica “Giulio Natta”, the Grand Ufficiale della Repubblica Italiana, honorary degrees from the Universities of Bialystok in Poland and Barcelona in Spain and in Milan. Other awards include the Hippocrates Prize, Mens Sana in Corpore Sano, Nuova Spoleto, Angelo dell’Anno, Alkmeon International Prize, Sant’Agostino Città di Bergamo International Prize, Il Campione della Scienza, Coppola Prize, Scienza e Società in the framework of the Premio Città di Firenze, Premio Rana d’Oro, Premio Barocco Città di Lecce, Premio Nazionale TV L’Altra Italia, Premio Chirone, Premio “Testimonial” LILT. Silvio Garattini is a Fellow of the New York Academy of Sciences, the American Association for the Advancement of Science, Honorary Fellow of the Royal College of Physicians (Pharmaceutical Medicine), London, Honorary Fellow of the Italian Society of Pharmacology and a member of many other Italian and international scientific societies. In over 50 years, the Mario Negri Institute for Pharmacological Research, under Professor Garattini's leadership, has published more than 14,000 scientific papers and more than 250 books, on topics ranging from cancer and its treatment to tumor immunology, neuro‐psycho‐pharmacology, cardiovascular, renal pharmacology and rare diseases. More than 7000 young researchers and technicians have qualified as specialists at the Institute.